Patent details

Basic Information

Publication number:

EP3236953

PCT Application Number:

US2015000303

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158262097

PCT Publication Number:

WO2016105531

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SITE SPECIFIC DOSING OF A BTK INHIBITOR

French Title of Invention:

DOSAGE SPÉCIFIQUE DE SITE D'UN INHIBITEUR DE BTK

German Title of Invention:

ORTSSPEZIFISCHE DOSIERUNG EINES BTK-INHIBITOR

SPC Number:

Dates

Filing date:

23/12/2015

Grant date:

11/11/2020

EP Publication Date:

01/11/2017

PCT Publication Date:

30/06/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

11/11/2020

EP B1 Publication Date:

11/11/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/12/2020

Expiration date:

23/12/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/11/2020

 

 

Name:

Principia Biopharma Inc.

Address:

220 E. Grand Ave., S. San Francisco, CA 94080, United States (US)

Inventor

1

Name:

NUNN, Philipp

Address:

United States (US)

2

Name:

BERNER, Bret

Address:

United States (US)

3

Name:

MASJEDIZADEH, Mohammad

Address:

United States (US)

Priority

Priority Number:

201462096809 P

Priority Date:

24/12/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/28; A61K 9/48; A61K 9/50; A61K 31/506; A61K 31/519;

Publication

European Patent Bulletin

Issue number:

202046

Publication date:

11/11/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages